Provention Bio, Inc. Profile Avatar - Palmy Investing

Provention Bio, Inc.

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and mon…

Biotechnology
US, Red Bank [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Provention Bio, Inc. (PRVB) to it's peer group.

Peer Group
RXDX MDGL AKRO IMVT ISEE RETA APLS Compare Together
Loading...
End of PRVB's Analysis
CIK: 1695357 CUSIP: 74374N102 ISIN: US74374N1028 LEI: - UEI: -
Secondary Listings
PRVB has no secondary listings inside our databases.